144 related articles for article (PubMed ID: 34899864)
1. A Novel Pyroptosis-Related Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Osteosarcoma.
Zhang Y; He R; Lei X; Mao L; Jiang P; Ni C; Yin Z; Zhong X; Chen C; Zheng Q; Li D
Front Genet; 2021; 12():780780. PubMed ID: 34899864
[TBL] [Abstract][Full Text] [Related]
2. Pyroptosis-Related Gene Signature Predicts Prognosis and Response to Immunotherapy and Medication in Pediatric and Young Adult Osteosarcoma Patients.
Guo C; Yang X; Li L
J Inflamm Res; 2024; 17():417-445. PubMed ID: 38269108
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a pyroptosis-related prognostic signature associated with osteosarcoma metastasis and immune infiltration.
Gong Z; Wan Y; Han E; Zhou X; Huang J; Yu H; Shi Y; Lian K
Medicine (Baltimore); 2024 Apr; 103(14):e37642. PubMed ID: 38579086
[TBL] [Abstract][Full Text] [Related]
4. Novel pyroptosis-related lncRNAs and ceRNAs predict osteosarcoma prognosis and indicate immune microenvironment signatures.
Yang M; Zheng H; Su Y; Xu K; Yuan Q; Cai Y; Aihaiti Y; Xu P
Heliyon; 2023 Nov; 9(11):e21503. PubMed ID: 38027935
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma.
Han S; Wang Q; Shen M; Zhang X; Wang J
Heliyon; 2024 Mar; 10(6):e27630. PubMed ID: 38515694
[TBL] [Abstract][Full Text] [Related]
6. Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma.
Chen W; Liao Y; Sun P; Tu J; Zou Y; Fang J; Chen Z; Li H; Chen J; Peng Y; Wen L; Xie X
J Transl Med; 2024 Jan; 22(1):66. PubMed ID: 38229155
[TBL] [Abstract][Full Text] [Related]
7. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma.
Hong X; Fu R
PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294
[TBL] [Abstract][Full Text] [Related]
8. Identification and preliminary validation of a four-gene signature to predict metastasis and survival in osteosarcoma.
Zhang Y; Lei X; He R; Mao L; Jiang P; Ni C; Zhong X; Yin Z; Wu X; Li D; Zheng Q
Am J Transl Res; 2021; 13(11):12264-12284. PubMed ID: 34956452
[TBL] [Abstract][Full Text] [Related]
9. Metastasis-Related Signature for Clinically Predicting Prognosis and Tumor Immune Microenvironment of Osteosarcoma Patients.
Zhang Q; Deng Z; Yang Y
Mol Biotechnol; 2023 Nov; 65(11):1836-1845. PubMed ID: 36807122
[TBL] [Abstract][Full Text] [Related]
10. Enhanced pyroptosis induction with pore-forming gene delivery for osteosarcoma microenvironment reshaping.
Nie JJ; Zhang B; Luo P; Luo M; Luo Y; Cao J; Wang H; Mao J; Xing Y; Liu W; Cheng Y; Wang R; Liu Y; Wu X; Jiang X; Cheng X; Zhang C; Chen DF
Bioact Mater; 2024 Aug; 38():455-471. PubMed ID: 38770426
[TBL] [Abstract][Full Text] [Related]
11. Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma.
Liu W; Xia K; Zheng D; Huang X; Wei Z; Wei Z; Guo W
BMC Cancer; 2023 Dec; 23(1):1179. PubMed ID: 38041020
[TBL] [Abstract][Full Text] [Related]
12. A Disulfidptosis-Related Gene Signature Associated with Prognosis and Immune Cell Infiltration in Osteosarcoma.
Chen P; Shen J
Bioengineering (Basel); 2023 Sep; 10(10):. PubMed ID: 37892851
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of single-cell and bulk RNA sequencing data reveals prognostic characteristics of lysosome-dependent cell death-related genes in osteosarcoma.
Wu Y; Yang J; Xu G; Chen X; Qu X
BMC Genomics; 2024 Apr; 25(1):379. PubMed ID: 38632516
[TBL] [Abstract][Full Text] [Related]
14. Ceramide metabolism-related prognostic signature and immunosuppressive function of ST3GAL1 in osteosarcoma.
Zou Y; Guo S; Liao Y; Chen W; Chen Z; Chen J; Wen L; Xie X
Transl Oncol; 2024 Feb; 40():101840. PubMed ID: 38029509
[TBL] [Abstract][Full Text] [Related]
15. RNA modification-related EIF4G2 is an immunotherapy determinant in osteosarcoma: A single-cell sequencing analysis.
Qin H; Yang S; Feng Z; Wu S; Cai T; Xie Z; Hu H
Environ Toxicol; 2024 Apr; ():. PubMed ID: 38578024
[TBL] [Abstract][Full Text] [Related]
16. Lipid metabolism-derived FAAH is a sensitive marker for the prognosis and immunotherapy of osteosarcoma patients.
Shi Y; Wu S; Zhang X; Cao Y; Zhang L
Heliyon; 2024 Jan; 10(1):e23499. PubMed ID: 38169921
[TBL] [Abstract][Full Text] [Related]
17. Comment on "Predicting metastasis at initial diagnosis and radiotherapy effectiveness in patients with metastatic osteosarcoma".
Liu G; Huang S; Hu Q; Chen C
J Cancer Res Clin Oncol; 2023 Nov; 149(15):14471-14472. PubMed ID: 37530799
[No Abstract] [Full Text] [Related]
18. Construction and validation of a novel cuproptosis-mitochondrion prognostic model related with tumor immunity in osteosarcoma.
Feng J; Wang J; Xu Y; Lu F; Zhang J; Han X; Zhang C; Wang G
PLoS One; 2023; 18(7):e0288180. PubMed ID: 37405988
[TBL] [Abstract][Full Text] [Related]
19. ALOX5AP is an Indicator for High CD8 Lymphocyte Infiltration and "Hot" Tumor Microenvironment in Osteosarcoma: A Bioinformatic Study.
Chen Y; Zeng C; Zhang X; Hua Q
Biochem Genet; 2023 Dec; 61(6):2363-2381. PubMed ID: 37041365
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a cuproptosis-related lncRNA model correlated to the cancer-associated fibroblasts enable the prediction prognosis of patients with osteosarcoma.
Wang X; Xie C; Lin L
J Bone Oncol; 2023 Feb; 38():100463. PubMed ID: 36569351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
